Alexander L. Neuwirth
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alexander L. Neuwirth has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Herbert John Cooper
Department of Orthopedic Surgery, Columbia University Irving Medical Center, New York, USA
8 shared publications - Roshan P. Shah
Department of Orthopedic Surgery, Columbia University Irving Medical Center, New York, NY, USA
6 shared publications - Carl L. Herndon
Columbia University Irving Medical Center, New York, NY, USA
3 shared publications - Jeffrey A. Geller
Department of Orthopedic Surgery, Columbia University Irving Medical Center, 622 W 168th St. New York, NY 10032 USA
3 shared publications - Nana Owusu-Sarpong
Department of Orthopedic Surgery, Columbia University Irving Medical Center, New York, NY, USA
3 shared publications Jeffrey A. Geller
Columbia Irving Medical Center, New York-Presbyterian Hospital, New York, NY, USA
2 shared publications
Latest Publications
- Open Access
- 19 October 2026
- Published by Wolters Kluwer Health in Journal of the American Academy of Orthopaedic Surgeons
Silk Dressings Are More Cost Effective Than 2-Octyl Cyanoacrylate Mesh in Hip and Knee Arthroplasty
Introduction: Wound complications are costly after primary and revision total hip and knee arthroplasty (TJA). Mesh with 2-octyl cyanoacrylate can perform well but is associated with hypersensitivity and wound-healing complications. Silk dressings have shown fewer adverse events. We compared dressing costs, examining direct and complication-related expenses. Methods: An IRB-exempt cost-effectiveness analysis was conducted using published data on complication rates, including hypersensitivity reactions, delayed wound healing, periprosthetic joint infection (PJI), and application times. Direct material costs were calculated and annualized using the manufacturer's suggested retail prices (MSRPs) and bulk-purchase rates. Indirect costs were calculated for surgical costs per minute and treatment of wound complications and PJI. Results: Direct material costs were $387 (MSRP) or $79 (bulk pricing) for mesh dressings versus $120 (MSRP) or $60 (bulk pricing) for silk. When application times, differential rates of sensitivity reactions, and wound complications and their management are applied to national TJA rates, mesh costs markedly more than silk by $939/patient (MSRP) and $690/patient (bulk pricing) (MSRP: $1,090 versus $151/patient; $1.89 billion versus $2.62 million/annum; bulk pricing: $781 versus $91/patient; $1.36 billion versus $158 million/annum). Excluding PJI, which has a relationship that is several degrees away from dressing type, mesh was still more expensive than silk by $484/patient (MSRP) and $235/patient (bulk pricing) (MSRP: $634/patient versus $150; $1.1 billion versus $262 million/annum; bulk pricing: $326/patient versus $91; $566 million vs. $158 million/annum). Conclusion: Silk dressings are more cost-effective than mesh dressings because of shorter application time, fewer complications, and lower pricing. For clinical and economic reasons, silk dressings should be considered for TJA.
- 19 October 2026
- Published by Wolters Kluwer Health in Journal of the American Academy of Orthopaedic Surgeons
Open AccessSilk Dressings Are More Cost Effective Than 2-Octyl Cyanoacrylate Mesh in Hip and Knee Arthroplasty
Introduction: Wound complications are costly after primary and revision total hip and knee arthroplasty (TJA). Mesh with 2-octyl cyanoacrylate can perform well but is associated with hypersensitivity and wound-healing complications. Silk dressings have shown fewer adverse events. We compared dressing costs, examining direct and complication-related expenses. Methods: An IRB-exempt cost-effectiveness analysis was conducted using published data on complication rates, including hypersensitivity reactions, delayed wound healing, periprosthetic joint infection (PJI), and application times. Direct material costs were calculated and annualized using the manufacturer's suggested retail prices (MSRPs) and bulk-purchase rates. Indirect costs were calculated for surgical costs per minute and treatment of wound complications and PJI. Results: Direct material costs were $387 (MSRP) or $79 (bulk pricing) for mesh dressings versus $120 (MSRP) or $60 (bulk pricing) for silk. When application times, differential rates of sensitivity reactions, and wound complications and their management are applied to national TJA rates, mesh costs markedly more than silk by $939/patient (MSRP) and $690/patient (bulk pricing) (MSRP: $1,090 versus $151/patient; $1.89 billion versus $2.62 million/annum; bulk pricing: $781 versus $91/patient; $1.36 billion versus $158 million/annum). Excluding PJI, which has a relationship that is several degrees away from dressing type, mesh was still more expensive than silk by $484/patient (MSRP) and $235/patient (bulk pricing) (MSRP: $634/patient versus $150; $1.1 billion versus $262 million/annum; bulk pricing: $326/patient versus $91; $566 million vs. $158 million/annum). Conclusion: Silk dressings are more cost-effective than mesh dressings because of shorter application time, fewer complications, and lower pricing. For clinical and economic reasons, silk dressings should be considered for TJA.
- 21 July 2026
- Published by Wolters Kluwer Health in Journal of the American Academy of Orthopaedic Surgeons
- Vol. 34 (22) , e3320-e3327
Chlorhexidine Gluconate and Hypersensitivity From 2-Octyl Cyanoacrylate Mesh Dressings
Background: Both 2-octyl cyanoacrylate mesh dressings and chlorhexidine gluconate are independently associated with hypersensitivity. Residual chlorhexidine antiseptic trapped under an impermeable mesh dressing may synergistically contribute to skin reactions. We hypothesized that an enhanced washing protocol before dressing application would reduce the incidence of hypersensitivity. We secondarily compared delayed wound healing, infection, and sensitization from prior exposure with mesh dressings. Methods: This retrospective study reviewed 214 hip and knee arthroplasty patients receiving 2% chlorhexidine gluconate/70% isopropyl alcohol skin paint and a 2-octyl cyanoacrylate mesh dressing. The standard wash protocol (n = 138) informally wiped the skin prep with saline. The enhanced wash protocol (n = 76) thoroughly removed the skin prep with an isopropyl alcohol-soaked sponge followed by a saline soaked sponge. The chart was reviewed for hypersensitivity, wound healing, infection, and prior exposure. Results: The enhanced wash protocol was associated with a notable decrease in the rate of hypersensitivity from 14.5 to 2.6% (OR 0.16, 95% CI, [0.04-0.70]). The two reactions in the enhanced protocol occurred immediately and both subsequently revealed a history of adhesive allergy. More folliculitis was observed in the enhanced group (3.9 vs. 0%, P = 0.04). No differences were observed in delayed wound healing, superficial infection, or deep infection ( P = 0.75, 0.53, and 1, respectively). Prior mesh exposure had no effect on hypersensitivity. Conclusion: We observed that thorough removal of durable chlorhexidine paint was associated with a lower incidence of hypersensitivity after application of impermeable mesh dressings. The study findings support efforts to reduce chlorhexidine concentration on the skin before the application of dressings. In the absence of a prospective study, we recommend making this inexpensive and simple protocol change before application of a 2-octyl cyanoacrylate mesh dressing to surgical wounds.
- 21 July 2026
- Published by Wolters Kluwer Health in Journal of the American Academy of Orthopaedic Surgeons
- Vol. 34 (22) , e3320-e3327
Chlorhexidine Gluconate and Hypersensitivity From 2-Octyl Cyanoacrylate Mesh Dressings
Background: Both 2-octyl cyanoacrylate mesh dressings and chlorhexidine gluconate are independently associated with hypersensitivity. Residual chlorhexidine antiseptic trapped under an impermeable mesh dressing may synergistically contribute to skin reactions. We hypothesized that an enhanced washing protocol before dressing application would reduce the incidence of hypersensitivity. We secondarily compared delayed wound healing, infection, and sensitization from prior exposure with mesh dressings. Methods: This retrospective study reviewed 214 hip and knee arthroplasty patients receiving 2% chlorhexidine gluconate/70% isopropyl alcohol skin paint and a 2-octyl cyanoacrylate mesh dressing. The standard wash protocol (n = 138) informally wiped the skin prep with saline. The enhanced wash protocol (n = 76) thoroughly removed the skin prep with an isopropyl alcohol-soaked sponge followed by a saline soaked sponge. The chart was reviewed for hypersensitivity, wound healing, infection, and prior exposure. Results: The enhanced wash protocol was associated with a notable decrease in the rate of hypersensitivity from 14.5 to 2.6% (OR 0.16, 95% CI, [0.04-0.70]). The two reactions in the enhanced protocol occurred immediately and both subsequently revealed a history of adhesive allergy. More folliculitis was observed in the enhanced group (3.9 vs. 0%, P = 0.04). No differences were observed in delayed wound healing, superficial infection, or deep infection ( P = 0.75, 0.53, and 1, respectively). Prior mesh exposure had no effect on hypersensitivity. Conclusion: We observed that thorough removal of durable chlorhexidine paint was associated with a lower incidence of hypersensitivity after application of impermeable mesh dressings. The study findings support efforts to reduce chlorhexidine concentration on the skin before the application of dressings. In the absence of a prospective study, we recommend making this inexpensive and simple protocol change before application of a 2-octyl cyanoacrylate mesh dressing to surgical wounds.
- Open Access
- 17 October 2024
- Published by Elsevier in Arthroplasty Today
- Vol. 30, 101513
Perioperative Outcomes of Intramedullary Nail vs Hemiarthroplasty vs Total Hip Arthroplasty for Intertrochanteric Fracture: An Analysis of 31,519 Cases
- 17 October 2024
- Published by Elsevier in Arthroplasty Today
- Vol. 30, 101513
Open AccessPerioperative Outcomes of Intramedullary Nail vs Hemiarthroplasty vs Total Hip Arthroplasty for Intertrochanteric Fracture: An Analysis of 31,519 Cases
- 22 June 2024
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 39 (12) , 2935-2941
2-Octyl-Cyanoacrylate Mesh Dressings for Total Joint Arthroplasty: Dressing Design Influences Risks of Wound Complications
- 22 June 2024
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 39 (12) , 2935-2941
2-Octyl-Cyanoacrylate Mesh Dressings for Total Joint Arthroplasty: Dressing Design Influences Risks of Wound Complications
- Open Access
- 19 May 2024
- Published by Springer Nature in Knee Surgery & Related Research
- Vol. 36 (1) , 1-13
Genicular nerve radiofrequency ablation: a systematic review of application for perioperative pain control in total knee arthroplasty and as treatment for chronic pain in well-appearing total knee arthroplasty
Background: Total knee arthroplasty (TKA) is a successful treatment for end-stage osteoarthritis, yet some patients still experience postoperative pain. Genicular nerve radiofrequency ablation (GNRFA) has become a potential modality to address pain in TKA. This systematic review aims to critically analyze the applicability of GNRFA in perioperative pain control prior to TKA, as well as a treatment modality for chronic painful well-appearing TKA. Methods: PubMed, Medline, EMBASE, Google Scholar, Scopus, and COCHRANE databases, as well as the ClinicalTrials.gov register, were reviewed. The search included randomized controlled trials and cohort studies. The sample population focused on two cohorts; those who underwent TKA and utilized intentional GNRFA as a perioperative pain control modality, and those utilizing the treatment modality for chronic pain in well-appearing TKA. GNRFA was the intervention studied, and postoperative outcomes were compared with the control group, which consisted of those not receiving GNRFA. Result: Eight total publications were identified as relevant to this search. Among the pre-TKA studies, there was variability in results; these inconsistencies were attributed to a lack of standardization, especially with regard to type, timing, and targeted nerves with ablation. Likewise, while the results were improved among the population with chronic painful TKA receiving GNRFA, these inconsistencies still existed. Conclusions: Current evidence suggests GNRFA as a possible pre-TKA intervention to potentially minimize opioid consumption, patient-reported pain, length of stay, and increased range of motion and activity. However, the short-lived duration in the setting of chronically painful well-appearing TKA represents a major barrier that warrants further investigation. Limitations include small sample size, heterogeneity, lack of standardization of techniques among studies, and lack of direct comparison and meta-analysis. Further research should focus on the standardization of technique as well as analyzing various patient and health-system-related factors that correlate with sustained positive outcomes.
- 19 May 2024
- Published by Springer Nature in Knee Surgery & Related Research
- Vol. 36 (1) , 1-13
Open AccessGenicular nerve radiofrequency ablation: a systematic review of application for perioperative pain control in total knee arthroplasty and as treatment for chronic pain in well-appearing total knee arthroplasty
Background: Total knee arthroplasty (TKA) is a successful treatment for end-stage osteoarthritis, yet some patients still experience postoperative pain. Genicular nerve radiofrequency ablation (GNRFA) has become a potential modality to address pain in TKA. This systematic review aims to critically analyze the applicability of GNRFA in perioperative pain control prior to TKA, as well as a treatment modality for chronic painful well-appearing TKA. Methods: PubMed, Medline, EMBASE, Google Scholar, Scopus, and COCHRANE databases, as well as the ClinicalTrials.gov register, were reviewed. The search included randomized controlled trials and cohort studies. The sample population focused on two cohorts; those who underwent TKA and utilized intentional GNRFA as a perioperative pain control modality, and those utilizing the treatment modality for chronic pain in well-appearing TKA. GNRFA was the intervention studied, and postoperative outcomes were compared with the control group, which consisted of those not receiving GNRFA. Result: Eight total publications were identified as relevant to this search. Among the pre-TKA studies, there was variability in results; these inconsistencies were attributed to a lack of standardization, especially with regard to type, timing, and targeted nerves with ablation. Likewise, while the results were improved among the population with chronic painful TKA receiving GNRFA, these inconsistencies still existed. Conclusions: Current evidence suggests GNRFA as a possible pre-TKA intervention to potentially minimize opioid consumption, patient-reported pain, length of stay, and increased range of motion and activity. However, the short-lived duration in the setting of chronically painful well-appearing TKA represents a major barrier that warrants further investigation. Limitations include small sample size, heterogeneity, lack of standardization of techniques among studies, and lack of direct comparison and meta-analysis. Further research should focus on the standardization of technique as well as analyzing various patient and health-system-related factors that correlate with sustained positive outcomes.
- 27 July 2022
- Published by Springer Nature
- p. 21-30
Anatomy of the ABMS Approach to the Hip
- 22 August 2020
- Published by Springer Nature in Current Reviews in Musculoskeletal Medicine
- Vol. 13 (6) , 675-679
What Is the Learning Curve for New Technologies in Total Joint Arthroplasty? A Review
Purpose of Review The adaptation of new technology in joint replacement surgery is often associated with a learning curve, as performance tends to improve with experience. The purpose of this review is to define the learning curve and its relevance to joint replacement surgery in the setting of new technological advances, and to draw analogies with the learning curve of basic surgical training. Recent Findings Assessing a surgeon’s learning curve for a new technology is complicated and difficult. With every learning curve, the first patients subjected to the novel technology may be at higher risk for adverse events until the learning curve is overcome and a steady state is reached. While measures of performance can be clear and direct in some professions, learning curves with new technology in total joint arthroplasty have been difficult to quantify. Most attempts measure surgical learning curves via an evaluation of the surgical process or patient outcomes. There are published results of both process (i.e., operative time, accuracy of implant position) and outcome measures (i.e., complication rate, revision rate) utilized as proxy for performance during learning curves. Summary We review the concept of the learning curve in joint replacement surgery, highlighting examples of learning curves with adaptation of new technologies, and conclude with a discussion of dilemmas and challenges.
- 22 August 2020
- Published by Springer Nature in Current Reviews in Musculoskeletal Medicine
- Vol. 13 (6) , 675-679
What Is the Learning Curve for New Technologies in Total Joint Arthroplasty? A Review
Purpose of Review The adaptation of new technology in joint replacement surgery is often associated with a learning curve, as performance tends to improve with experience. The purpose of this review is to define the learning curve and its relevance to joint replacement surgery in the setting of new technological advances, and to draw analogies with the learning curve of basic surgical training. Recent Findings Assessing a surgeon’s learning curve for a new technology is complicated and difficult. With every learning curve, the first patients subjected to the novel technology may be at higher risk for adverse events until the learning curve is overcome and a steady state is reached. While measures of performance can be clear and direct in some professions, learning curves with new technology in total joint arthroplasty have been difficult to quantify. Most attempts measure surgical learning curves via an evaluation of the surgical process or patient outcomes. There are published results of both process (i.e., operative time, accuracy of implant position) and outcome measures (i.e., complication rate, revision rate) utilized as proxy for performance during learning curves. Summary We review the concept of the learning curve in joint replacement surgery, highlighting examples of learning curves with adaptation of new technologies, and conclude with a discussion of dilemmas and challenges.